CN1569187A - Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia - Google Patents
Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia Download PDFInfo
- Publication number
- CN1569187A CN1569187A CN 200410036727 CN200410036727A CN1569187A CN 1569187 A CN1569187 A CN 1569187A CN 200410036727 CN200410036727 CN 200410036727 CN 200410036727 A CN200410036727 A CN 200410036727A CN 1569187 A CN1569187 A CN 1569187A
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- rhizoma
- root
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a pure Chinese medicine for treating infecundity, dysgenesia and mastopathia which includes two preparations, the first of which is prepared from Chinese medicinal herbs including cyperus tuber, root of red rooted saliva, radix paeoniae rubrathe, root of herbaceous peony, peach kernels, safflower, Ligusticum wallichii, Chinese angelica root, capsule of weeping forsythia, licorice root, rhizoma corydalis, cattail pollen, zedoary, banksia rose, dried orange peel, sweetgum fruit, and haw, root bark of chinese wolf berry, dipsacus root.
Description
One, technical field: the present invention relates to a kind of mastotic pure Chinese medicine medicine of infertility that is used for the treatment of.
Two, background technology: at present, barrenness mostly is oviduct obstructive sterility, and salpingemphraxis hinders in collaterals of the uterus owing to gather, so that essence can not execute, and blood can not be taken the photograph, so do not wed and loss of fecundity.And the one-tenth of hernia abdominal mass, how because of in the miscarriage, the vessels of the uterus inanition, exopathogen is taken advantage of and is attacked, and being detained haunts, or internal damage by the excessive seven emotions, QI and blood is disorderly contrary, diet raw food, and ascending or descending movement of vital Qi is not normal, gas loses a surname's row, the stagnation of QI becomes the stasis of blood, hinder in sering, or invisible forming is gathered, therefore, the cause of disease of obstructive oviduct barrenness, pathogenesis should be qi depression to blood stasis.Since qi-blood disharmony, thus internal organs influenced, and particularly Liver and kidney two is dirty, and eight extra-channel is dashed wantonly two arteries and veins imbalance, so clinical common patient has depressed emotion, through the fore udder distending pain, face through inferior belly gas pain, through row piece is arranged, menoxenia or amenorrhea, symptoms such as ache of the spinal column, and in the majority with excess syndrome.The treatment means doctor trained in Western medicine is with hydrotubation or ventilation or uterine cavity injection treatment, though produce effect, undesirable.
Three, summary of the invention: the purpose of this invention is to provide a kind of mastotic pure Chinese medicine medicine of treatment barrenness that is specifically designed to.
The objective of the invention is to realize in the following manner:
Medicine of the present invention comprises two kinds of preparations, and first kind is to be made by the raw material of following weight ratio basically: Rhizoma Cyperi 5-9 part, Radix Salviae Miltiorrhizae 9-29 part, Radix Paeoniae Rubra 5-9 part, Radix Paeoniae Alba 5-9 part, Semen Persicae 5-9 part, Flos Carthami 5-9 part, Rhizoma Chuanxiong 2-5 part, Radix Angelicae Sinensis 5-12 part, Fructus Forsythiae 5-12 part, Fructus Foeniculi 2-5 part, Caulis Trachelospermi 5-9 part, Radix Glycyrrhizae 2-5 part, Rhizoma Corydalis 5-9 part, Pollen Typhae 5-9 part, Rhizoma Sparganii 5-9 part, high art 5-9 part, Radix Aucklandiae 5-9 part, Pericarpium Citri Reticulatae 5-9 part, Fructus Liquidambaris 5-9 part, Fructus Crataegi 5-9 part, Cortex Lycii 5-9 part, Radix Dipsaci 2-5 part;
Second kind is to be made by the raw material of following weight ratio basically: Rhizoma Cyperi 5-9 part, Radix Salviae Miltiorrhizae 9-29 part, Radix Paeoniae Rubra 5-9 part, Radix Paeoniae Alba 5-9 part, Semen Persicae 5-9 part, Flos Carthami 5-9 part, Rhizoma Chuanxiong 2-5 part, Radix Angelicae Sinensis 5-12 part, Fructus Forsythiae 5-12 part, Fructus Foeniculi 2-5 part, Caulis Trachelospermi 5-9 part, Radix Glycyrrhizae 2-5 part, Rhizoma Corydalis 5-9 part, Pollen Typhae 5-9 part, Rhizoma Sparganii 5-9 part, high art 5-9 part, Radix Aucklandiae 5-9 part, Pericarpium Citri Reticulatae 5-9 part, Fructus Liquidambaris 5-9 part, Cortex Lycii 5-9 part, Cortex Moutan 4-17 part, Radix Angelicae Dahuricae 5-16 part, Fructus Aurantii 5-9 part, Radix Glycyrrhizae 2-5 part, Squama Manis 1-3 part, Olibanum 3-10 part, Myrrha 3-10 part.
Its method for production is:
First kind of preparation is that various raw materials are concocted one by one, and pulverization mixes after crossing the 200-300 mesh sieve, makes powder or pill, and per 6 gram medicines are a bag.
Second kind of preparation be with various raw materials one by one porphyrize mix after crossing the 200-300 mesh sieve, can be made into every content of dispersion is 450 milligrams of pills or capsule.
Advantage of the present invention is the cause of disease of having caught the morbidity of barrenness breast disease, follows doctor's ultimate principle, and the basic principle of determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs understanding disease and treatment disease is to the special research and the processing method of disease.Plan to implement the gasification stasis of blood, the removing food stagnancy block removing, QI and blood a surname row, Liver and kidney internal organs meridian function recovers naturally, and then tire is pregnant becomes, and lump in breast can disappear.With Drug therapy barrenness breast disease of the present invention have short treating period, cure rate can reach more than 85%, control the back and do not have advantages such as recurrence.
Four, the specific embodiment: with the raw material of following weight ratio: Rhizoma Cyperi 5-9 part, Radix Salviae Miltiorrhizae 9-29 part, Radix Paeoniae Rubra 5-9 part, Radix Paeoniae Alba 5-9 part, Semen Persicae 5-9 part, Flos Carthami 5-9 part, Rhizoma Chuanxiong 2-5 part, Radix Angelicae Sinensis 5-12 part, Fructus Forsythiae 5-12 part, Fructus Foeniculi 2-5 part, Caulis Trachelospermi 5-9 part, Radix Glycyrrhizae 2-5 part, Rhizoma Corydalis 5-9 part, Pollen Typhae 5-9 part, Rhizoma Sparganii 5-9 part, high art 5-9 part, Radix Aucklandiae 5-9 part, Pericarpium Citri Reticulatae 5-9 part, Fructus Liquidambaris 5-9 part, Fructus Crataegi 5-9 part, Cortex Lycii 5-9 part, Radix Dipsaci 2-5 part, pill was made in mixing after pulverization was crossed the 200-300 mesh sieve, per 6 gram medicines are a bag, make first kind of preparation; Raw material with following weight ratio: Rhizoma Cyperi 5-9 part, Radix Salviae Miltiorrhizae 9-29 part, Radix Paeoniae Rubra 5-9 part, Radix Paeoniae Alba 5-9 part, Semen Persicae 5-9 part, Flos Carthami 5-9 part, Rhizoma Chuanxiong 2-5 part, Radix Angelicae Sinensis 5-12 part, Fructus Forsythiae 5-12 part, Fructus Foeniculi 2-5 part, Caulis Trachelospermi 5-9 part, Radix Glycyrrhizae 2-5 part, Rhizoma Corydalis 5-9 part, Pollen Typhae 5-9 part, Rhizoma Sparganii 5-9 part, high art 5-9 part, Radix Aucklandiae 5-9 part, Pericarpium Citri Reticulatae 5-9 part, Fructus Liquidambaris 5-9 part, Cortex Lycii 5-9 part, Cortex Moutan 4-17 part, Radix Angelicae Dahuricae 5-16 part, Fructus Aurantii 5-9 part, Radix Glycyrrhizae 2-5 part, Squama Manis 1-3 part, Olibanum 3-10 part, Myrrha 3-10 part, porphyrize mixes after crossing the 200-300 mesh sieve one by one, makes every content of dispersion and be 450 milligrams capsule.Select oviduct obstructive sterility case 108 examples clinically, wherein 72 routine patients row hysterosalpingography or the cold shadow of uterus and fallopian tube Portugal amine radiographies, 36 customary tubal patent test by liquid instillation arts.In 72 example palace Salpingography cases, matter portion blocks 8 examples between the fallopian tube bilateral, and the bilateral isthmus blocks 17 examples, and the bilateral ampulla blocks 16 examples, and bilateral umbrella portion blocks 23 examples, and each one is mixed and hydrosalpinx 8 examples.Take medicine of the present invention for above-mentioned case, its usage is: 30 days is a course of treatment, at first first kind of preparation is taken twice every day, and (medicine) being taken before meal was obeyed 15 days with each bag, obeyed second kind of preparation again in later 15 days, every day twice, each 6-8 grain.Take medicine and carry out Salpingography or logical liquid after a course of treatment, the nonresponder is obeyed one to two course of treatment again.Its therapeutic outcome is most patients fruits that promptly take effect one to two course of treatment of taking medicine, and total effective 98 examples account for 89.8%, the rate 85.2% of recovering; Wherein pregnant 22 people, pregnancy rate 20.4%; Invalid 11 examples, inefficiency 10.2%.Because of 8 examples of not ovulating in total effectively case, bad 12 examples of luteal function, dysspermatism 16 examples in the bridegroom's or husband's side are so obviously influenced pregnancy rate.108 routine patients from administration, medicine of the present invention shows as the effect of isolated uterine, fallopian tube smooth muscle can make uterus, fallopian tube smooth muscle relaxation, this helps the elimination of salpingitis tubal and the reparation of tissue, help the elimination and the absorption of foreign body in the fallopian tube, thereby help oviducal unimpeded.In addition, the salpingitis tubal patient often with the clinical manifestation of abdominal discomfort or pain, this lax uterus of medicine of the present invention, the effect of fallopian tube smooth muscle can help the alleviation of patient's clinical symptoms.
Below provide three model cases of the present invention:
Case 1 Zhao so-and-so, the woman, 33 years old, in calendar year 2001 first visit on April 26, the 6 years unpregnancies of marrying.Menoxenia is faced through lower abdominal distention pain, through the fore udder distending pain, susceptible to lose temper due to restlessness, the amount of passing through polychrome is red, edema of lower limbs, leucorrhea with yellow discharge usually, the thick amount of matter is many, stringy and thready pulse, thin fur matter is dim red, gynecologial examination, and vagina is smooth, cervix uteri is gently rotten, palace body hypsokinesis, normal size adnexa feminine gender, hysterosalpingography, the bilateral salpingitis, umbrella end completeness is blocked.Take medicine of the present invention after one 30 days courses of treatment, look into Salpingography again, the bilateral fallopian tube is unobstructed, and the main suit spends more than 10 day and do not go menstrual period, cold physique occurs, plays symptoms such as cold evil morning, and the test of urine very early pregnancy is positive.
Case 2 week so-and-so, the woman, 28 years old, the teacher, the 7 years unpregnancies of marrying, husband's seminal fluid is conventional normal, first visit on January 4 in 2002, Salpingography, the obstruction of bilateral fallopian tube adhesion.Gynecologial examination: the bilateral adnexa increases that thick tenderness is obvious, and the uterus is slightly little, thready and rapid pulse, and the dim tongue of body of the tongue is few, irregular menstruation, front and back are indefinite, clot, breast swell and pain.After course of therapy of medicine of the present invention, pertubation, this moment is logical and not smooth, obey a course of treatment again after, Salpingography is unimpeded fully, in further consultation on May 8 in 2002, the very early pregnancy test was become pregnant.
Case 3 grandsons so-and-so, the woman, 29 years old, the cadre, first visit in April, 2003 is because of the housework dispute, inability of coition is arranged, spirit depressing, it is fixed not have menstrual period, row and not walking, wed 3 years infertile, the preceding susceptible to lose temper due to restlessness of menstrual onset, insomnia and dreamful sleep, distending pain of the breast, the time sore nipples is arranged, can not touch clothing, piece is arranged.With the diagnosis of infrared ray mammary gland instrument, cyclomastopathy is arranged.Lower abdomen is had a pain and is stirred thorn as club when passing through, and blood is black piece, and stringy pulse tongue limit one side has several somes ecchymosis, and disorder of QI is with the passing of time, strongly fragrantly must return liver, qi depression to blood stasis, and cause infertile, invalid through multi-treatment in the past.Come this with medicine of the present invention after 2 courses of treatment, cyclomastopathy and other are normal, ask to know and become pregnant after in October, 2003.
Claims (1)
1, the mastotic pure Chinese medicine medicine of a kind of treatment infertility, it is characterized in that: this medicine comprises two kinds of preparations, first kind is to be made by the raw material of following weight ratio basically: Rhizoma Cyperi 5-9 part, Radix Salviae Miltiorrhizae 9-29 part, Radix Paeoniae Rubra 5-9 part, Radix Paeoniae Alba 5-9 part, Semen Persicae 5-9 part, Flos Carthami 5-9 part, Rhizoma Chuanxiong 2-5 part, Radix Angelicae Sinensis 5-12 part, Fructus Forsythiae 5-12 part, Fructus Foeniculi 2-5 part, Caulis Trachelospermi 5-9 part, Radix Glycyrrhizae 2-5 part, Rhizoma Corydalis 5-9 part, Pollen Typhae 5-9 part, Rhizoma Sparganii 5-9 part, high art 5-9 part, Radix Aucklandiae 5-9 part, Pericarpium Citri Reticulatae 5-9 part, Fructus Liquidambaris 5-9 part, Fructus Crataegi 5-9 part, Cortex Lycii 5-9 part, Radix Dipsaci 2-5 part;
Second kind is to be made by the raw material of following weight ratio basically: Rhizoma Cyperi 5-9 part, Radix Salviae Miltiorrhizae 9-29 part, Radix Paeoniae Rubra 5-9 part, Radix Paeoniae Alba 5-9 part, Semen Persicae 5-9 part, Flos Carthami 5-9 part, Rhizoma Chuanxiong 2-5 part, Radix Angelicae Sinensis 5-12 part, Fructus Forsythiae 5-12 part, Fructus Foeniculi 2-5 part, Caulis Trachelospermi 5-9 part, Radix Glycyrrhizae 2-5 part, Rhizoma Corydalis 5-9 part, Pollen Typhae 5-9 part, Rhizoma Sparganii 5-9 part, high art 5-9 part, Radix Aucklandiae 5-9 part, Pericarpium Citri Reticulatae 5-9 part, Fructus Liquidambaris 5-9 part, Cortex Lycii 5-9 part, Cortex Moutan 4-17 part, Radix Angelicae Dahuricae 5-16 part, Fructus Aurantii 5-9 part, Radix Glycyrrhizae 2-5 part, Squama Manis 1-3 part, Olibanum 3-10 part, Myrrha 3-10 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410036727 CN1287844C (en) | 2004-04-27 | 2004-04-27 | Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410036727 CN1287844C (en) | 2004-04-27 | 2004-04-27 | Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1569187A true CN1569187A (en) | 2005-01-26 |
CN1287844C CN1287844C (en) | 2006-12-06 |
Family
ID=34481578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410036727 Expired - Fee Related CN1287844C (en) | 2004-04-27 | 2004-04-27 | Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1287844C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101199782B (en) * | 2007-12-17 | 2010-06-02 | 席凤英 | Chinese medicine composition of oral administration for treating irregular menstruation |
CN101816737A (en) * | 2010-05-27 | 2010-09-01 | 田玄章 | Chinese medicinal preparation for treating infertility |
CN101138588B (en) * | 2006-09-08 | 2010-09-08 | 山东轩竹医药科技有限公司 | Pharmaceutical composition for treating gland hyperplasia and method of preparing the same |
CN102641476A (en) * | 2012-05-07 | 2012-08-22 | 韩德礼 | Traditional Chinese medicine preparation for treating infertility |
CN104116796A (en) * | 2014-08-12 | 2014-10-29 | 李海英 | Medicinal composition for treating hyperplasia of mammary glands |
-
2004
- 2004-04-27 CN CN 200410036727 patent/CN1287844C/en not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101138588B (en) * | 2006-09-08 | 2010-09-08 | 山东轩竹医药科技有限公司 | Pharmaceutical composition for treating gland hyperplasia and method of preparing the same |
CN101199782B (en) * | 2007-12-17 | 2010-06-02 | 席凤英 | Chinese medicine composition of oral administration for treating irregular menstruation |
CN101816737A (en) * | 2010-05-27 | 2010-09-01 | 田玄章 | Chinese medicinal preparation for treating infertility |
CN101816737B (en) * | 2010-05-27 | 2011-08-24 | 田玄章 | Chinese medicinal preparation for treating infertility |
CN102641476A (en) * | 2012-05-07 | 2012-08-22 | 韩德礼 | Traditional Chinese medicine preparation for treating infertility |
CN104116796A (en) * | 2014-08-12 | 2014-10-29 | 李海英 | Medicinal composition for treating hyperplasia of mammary glands |
CN104116796B (en) * | 2014-08-12 | 2016-03-09 | 李海英 | A kind of pharmaceutical composition for the treatment of cyclomastopathy |
Also Published As
Publication number | Publication date |
---|---|
CN1287844C (en) | 2006-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101850086B (en) | Chinese medicinal composition for treating symptom of gallstones and preparation method thereof | |
CN101912593B (en) | Medicament for treating dysmenorrheal and preparation method thereof | |
CN101966322A (en) | Traditional Chinese medicinal composition for treating ovarian cyst and preparation method thereof | |
CN101966313A (en) | Chinese medicinal composition for treating female infertility and preparation method thereof | |
CN103585378A (en) | A Chinese medicinal composition for treating female infertility, and its preparation method | |
CN101342353A (en) | Traditional Chinese medicine preparation for treating barrenness and preparation method thereof | |
CN101653590B (en) | Medicine for treating habitual abortion and preparation method thereof | |
CN104208554A (en) | Traditional Chinese medicine mainly for treating multiple female diseases | |
CN101085301A (en) | Oral administration traditional Chinese medicine composition for treating mammary cancer | |
CN104435519B (en) | A kind of pharmaceutical composition for treating primary dysmenorrhea | |
CN1287844C (en) | Pure Chinese medicine for treating infecundity, dysgenesia and mastopathia | |
CN100333782C (en) | Female nutritive tonic capsule | |
CN102526620B (en) | Traditional Chinese medicinal composition for treating gynecological inflammation and application of same | |
CN102343019B (en) | Chinese medicinal composition for treating amenorrhea and preparation method of preparation thereof | |
CN101366878A (en) | Traditional Chinese medicine for female acyesis and aphoria and preparation method thereof | |
CN105833209B (en) | Traditional Chinese medicine composition for treating endometriosis | |
CN104644996A (en) | Medicine composition for treating hyperplasia of mammary glands and application thereof | |
CN104352867A (en) | Traditional Chinese medicine composition for treating gestational depression | |
CN1081063C (en) | Fetus-protecting instant particles for treating habitual or threatened abortion | |
CN102961662B (en) | Medicine for treating gastric ulcer and preparation method thereof | |
CN106581299A (en) | Traditional Chinese medicinal composition for improving kidney qi deficiency syndrome of people of middle aged and elderly people, and application thereof | |
CN105535199A (en) | Pharmaceutical preparation for treating polycystic ovarian syndromes accompanied with mammary gland hyperplasia | |
CN104173952A (en) | Traditional Chinese medicine composition for treating benign ovarian tumor | |
CN105597020A (en) | Pharmaceutical composition for treating polycystic ovarian syndrome combined with mammary gland hyperplasia | |
CN105311396A (en) | Traditional Chinese medicine preparation for treating hypomenorrhea caused by thin endometrium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |